Which nation will produce the long-acting cabotegravir generic version of the HIV prevention drug?.
South Africa.
2023 May
|
|
4/5 |
The long-acting cabotegravir (CAB-LA) drug, used to prevent HIV, will soon be produced in South Africa in a generic form that is both affordable and effective, making it the first time that the nation does so. The decision is significant because only 38 countries on the African continent produce the majority of the continent's medicines, which leaves less than 40% of those produced domestically.